MEP55908A - Utilzation of powder preparations containig hydroxypvridones for treating leg ulcers and decubitus ulcers - Google Patents
Utilzation of powder preparations containig hydroxypvridones for treating leg ulcers and decubitus ulcersInfo
- Publication number
- MEP55908A MEP55908A MEP-559/08A MEP55908A MEP55908A ME P55908 A MEP55908 A ME P55908A ME P55908 A MEP55908 A ME P55908A ME P55908 A MEP55908 A ME P55908A
- Authority
- ME
- Montenegro
- Prior art keywords
- ulcers
- hydroxypvridones
- utilzation
- containig
- powder preparations
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 208000005230 Leg Ulcer Diseases 0.000 title 1
- 208000004210 Pressure Ulcer Diseases 0.000 title 1
- 239000000843 powder Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 1
- 239000006104 solid solution Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19802708A DE19802708A1 (de) | 1998-01-24 | 1998-01-24 | Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren |
| PCT/EP1999/000105 WO1999037300A1 (de) | 1998-01-24 | 1999-01-11 | Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ME00390B ME00390B (me) | 2011-05-10 |
| MEP55908A true MEP55908A (en) | 2011-05-10 |
Family
ID=7855595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-559/08A MEP55908A (en) | 1998-01-24 | 1999-01-11 | Utilzation of powder preparations containig hydroxypvridones for treating leg ulcers and decubitus ulcers |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6534528B1 (pl) |
| EP (1) | EP1049468B1 (pl) |
| JP (1) | JP5127091B2 (pl) |
| KR (1) | KR100597332B1 (pl) |
| CN (1) | CN1128619C (pl) |
| AR (1) | AR016445A1 (pl) |
| AT (1) | ATE360418T1 (pl) |
| AU (1) | AU752406B2 (pl) |
| BR (1) | BR9907734A (pl) |
| CA (1) | CA2319359C (pl) |
| CY (1) | CY1106684T1 (pl) |
| DE (2) | DE19802708A1 (pl) |
| DK (1) | DK1049468T3 (pl) |
| ES (1) | ES2285829T3 (pl) |
| HR (1) | HRP20000496A2 (pl) |
| HU (1) | HU228824B1 (pl) |
| IL (1) | IL137453A (pl) |
| ME (1) | MEP55908A (pl) |
| NZ (1) | NZ505898A (pl) |
| PL (1) | PL192550B1 (pl) |
| PT (1) | PT1049468E (pl) |
| RS (1) | RS50903B (pl) |
| RU (1) | RU2212239C2 (pl) |
| SI (1) | SI1049468T1 (pl) |
| SK (1) | SK285350B6 (pl) |
| TR (1) | TR200002118T2 (pl) |
| WO (1) | WO1999037300A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001122804A (ja) * | 1999-10-28 | 2001-05-08 | Sato Pharmaceutical Co Ltd | リン酸コーンスターチ配合外用医薬組成物 |
| EP1354586A1 (en) * | 2002-04-20 | 2003-10-22 | Aventis Pharma Deutschland GmbH | The use of hydroxpyridone-derivatives in wound healing |
| US20060257439A1 (en) * | 2005-03-29 | 2006-11-16 | Sabnis Ram W | Cleansing compositions with color changing indicator |
| RU2326665C1 (ru) * | 2007-04-03 | 2008-06-20 | Марвел ЛайфСайнсез Лимитед, Великобритания | Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием |
| JP5901076B2 (ja) * | 2010-07-27 | 2016-04-06 | クラリアント・ファイナンス・（ビーブイアイ）・リミテッド | 過酸化水素又は過酸化水素遊離物質を安定化するためのヒドロキシピリドン類又はそれらの塩の使用 |
| MX2013001095A (es) * | 2010-07-27 | 2013-03-12 | Clariant Finance Bvi Ltd | Composiciones que comprenden peroxido de hidrogeno o sustancias donadoras de peroxido de hidrogeno. |
| CA2981616C (en) | 2015-04-06 | 2025-06-17 | Arcellx, Inc. | De novo binding domain polypeptides and their uses |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2540218A (en) | 1947-08-25 | 1951-02-06 | Squibb & Sons Inc | 2-hydroxy-pyridine-n-oxide and process for preparing same |
| DE3779352D1 (de) * | 1986-04-18 | 1992-07-02 | Hoechst Ag | 1-hydroxy-2-pyridone, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten, sowie bei der herstellung der 1-hydroxy-2-pyridone gebildete zwischenprodukte. |
| JPS63264504A (ja) * | 1987-04-17 | 1988-11-01 | Shinto Paint Co Ltd | 工業用防カビ組成物 |
| US4956184A (en) * | 1988-05-06 | 1990-09-11 | Alcide Corporation | Topical treatment of genital herpes lesions |
| CA2046801C (en) * | 1990-08-07 | 2002-02-26 | Peter D. Davis | Substituted pyrroles |
| DE4333893A1 (de) * | 1993-10-05 | 1995-04-06 | Hoechst Ag | Kosmetische Zubereitungen |
| DK0865278T3 (da) * | 1995-12-04 | 2002-09-09 | Aventis Pharma Gmbh | Anvendelse af 1-hydroxy-2-pyridoner til behandling af slimhinde-sygdomme, som er vanskeligt at behandle |
-
1998
- 1998-01-24 DE DE19802708A patent/DE19802708A1/de not_active Withdrawn
-
1999
- 1999-01-11 EP EP99902528A patent/EP1049468B1/de not_active Expired - Lifetime
- 1999-01-11 DK DK99902528T patent/DK1049468T3/da active
- 1999-01-11 WO PCT/EP1999/000105 patent/WO1999037300A1/de not_active Ceased
- 1999-01-11 RU RU2000122313/14A patent/RU2212239C2/ru active
- 1999-01-11 AU AU22787/99A patent/AU752406B2/en not_active Expired
- 1999-01-11 ES ES99902528T patent/ES2285829T3/es not_active Expired - Lifetime
- 1999-01-11 TR TR2000/02118T patent/TR200002118T2/xx unknown
- 1999-01-11 IL IL13745399A patent/IL137453A/xx not_active IP Right Cessation
- 1999-01-11 CN CN99802327A patent/CN1128619C/zh not_active Expired - Lifetime
- 1999-01-11 US US09/600,903 patent/US6534528B1/en not_active Expired - Lifetime
- 1999-01-11 KR KR1020007008050A patent/KR100597332B1/ko not_active Expired - Lifetime
- 1999-01-11 HR HR20000496A patent/HRP20000496A2/hr not_active Application Discontinuation
- 1999-01-11 JP JP2000528282A patent/JP5127091B2/ja not_active Expired - Lifetime
- 1999-01-11 RS YUP-437/00A patent/RS50903B/sr unknown
- 1999-01-11 PT PT99902528T patent/PT1049468E/pt unknown
- 1999-01-11 SK SK1089-2000A patent/SK285350B6/sk not_active IP Right Cessation
- 1999-01-11 BR BR9907734-5A patent/BR9907734A/pt not_active Application Discontinuation
- 1999-01-11 CA CA002319359A patent/CA2319359C/en not_active Expired - Lifetime
- 1999-01-11 NZ NZ505898A patent/NZ505898A/en not_active IP Right Cessation
- 1999-01-11 HU HU0200851A patent/HU228824B1/hu unknown
- 1999-01-11 DE DE59914312T patent/DE59914312D1/de not_active Expired - Lifetime
- 1999-01-11 SI SI9930962T patent/SI1049468T1/sl unknown
- 1999-01-11 PL PL342055A patent/PL192550B1/pl unknown
- 1999-01-11 AT AT99902528T patent/ATE360418T1/de active
- 1999-01-11 ME MEP-559/08A patent/MEP55908A/xx unknown
- 1999-01-21 AR ARP990100243A patent/AR016445A1/es unknown
-
2007
- 2007-06-28 CY CY20071100855T patent/CY1106684T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101237A1 (hu) | Elnyújtott kioldódású gyógyszerkészítmények | |
| BR0015567A (pt) | Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos | |
| AU2002316811A1 (en) | Stable formulation of modified glp-1 | |
| AU2093101A (en) | Compositions for efficient release of active ingredients | |
| NO20011471D0 (no) | Nye orale vedvarende frigivelsesformuleringer | |
| AU2001263229A1 (en) | Compositions and methods for administration of pharmacologically active compounds | |
| NO308538B1 (no) | Imidazo (4,5-c) kinolinaminer | |
| NO20031692D0 (no) | Fremgangsmåte for fremstilling av pulverformuleringer | |
| FI960032L (fi) | Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten | |
| ITFI930247A1 (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
| FI973452L (fi) | Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen | |
| PL339290A1 (en) | Pharmacological preparation containing clodronate as its active ingredient and silicated monocrystalline cellulose as excipient | |
| EE05383B1 (et) | Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon | |
| NO20002977D0 (no) | Terapeutisk formulering for administrasjon av tolterodin med kontrollert frigivelse | |
| HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
| CO5720000A2 (es) | Derivados de macrolidos con actividad antiinflamatoria, su procedimiento de sintesis y composiciones farmaceuticas que los contienen | |
| FI19991806L (fi) | Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus | |
| DE69919155D1 (de) | Präparationen zur kontrollierten freisetzung | |
| FI951357L (fi) | Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen | |
| ATE220547T1 (de) | Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung | |
| MEP55908A (en) | Utilzation of powder preparations containig hydroxypvridones for treating leg ulcers and decubitus ulcers | |
| IS2258B (is) | Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni | |
| DE59909341D1 (de) | Retardformulierungen von pflanzenschutzwirkstoffen | |
| NO985145L (no) | Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler | |
| IT1256623B (it) | Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche |